Cholangiocarcinomas Terminated Phase 1 Trials for Bevacizumab (DB00112)

Also known as: Cholangiocarcinoma / Cholangiocarcinoma NOS / Cholangiocarcinoma of biliary tract

IndicationStatusPhase
DBCOND0051818 (Cholangiocarcinomas)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00426829Proton Therapy and Bevacizumab for Primary Liver TumorsTreatment